Critical Reviews in Oncology Hematology

Papers
(The H4-Index of Critical Reviews in Oncology Hematology is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Harnessing tumor metabolism during cancer treatment: A narrative review of emerging dietary approaches292
Efficacy of PD-1/PD-L1 immunotherapy on brain metastatic non-small-cell lung cancer and treatment-related adverse events: A systematic review193
A bone paradigm challenging the standard model of myeloma oncogenesis148
Dysregulation of systemic immunity in colorectal cancer and its clinical applications as biomarkers and therapeutics133
Stereotactic body radiotherapy as an alternative to brachytherapy in cervical cancer (SCORE): A systematic review and meta-analysis128
Double agents in immunotherapy: Unmasking the role of antibody drug conjugates in immune checkpoint targeting112
Direct and indirect effects on child neurocognitive development when maternal cancer is diagnosed during pregnancy: What do we know so far?103
Editorial Board93
Surface-Enhanced Raman Scattering (SERS) combined with machine learning enables accurate diagnosis of cervical cancer: From molecule to cell to tissue level90
Novel bioengineered drugs with immunotherapies for malignant pleural effusion: Remodulate tumor immune microenvironment and activate immune system89
Tyrosine kinase inhibitors in cancers: Treatment optimization – Part II80
The BCL-2–tumor microenvironment axis: Mechanisms of immune suppression, resistance, and pathways to therapeutic reprogramming77
Skin barrier dysfunction in cutaneous T-cell lymphoma: From pathogenic mechanism of barrier damage to treatment75
Letter to the Editor regarding the article “A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs app75
Mapping the research landscape of HPV-positive oropharyngeal cancer: a bibliometric analysis70
Instruments and scales for the evaluation of acute radiation dermatitis: A systematic review69
Navigating management of localized prostate cancer in the geriatric population63
Systemic immune-inflammation index as a predictor of survival in non-small cell lung cancer patients undergoing immune checkpoint inhibition: A systematic review and meta-analysis62
Development of treatment strategies for advanced HER2-positive gastric cancer: Insights from clinical trials61
Targeted doublet therapy with encorafenib and cetuximab for BRAF V600E-mutant metastatic colorectal cancer: A systematic review and meta-analysis55
Beyond monospecificity: The modular revolution of bispecific immunotherapeutics54
Unveiling the Role of JAK2/STAT3 signaling in chemoresistance of gynecological cancers: From mechanisms to therapeutic implications51
Stereotactic body radiation therapy versus conventional external beam radiation therapy for painful bone metastases: A systematic review and meta-analysis of randomized trials50
Comparative efficacy of first-line therapies for PD-L1-negative advanced NSCLC: A network meta-analysis with reconstructed survival curves49
Microbiome dynamics in breast cancer: Mechanisms, therapeutic impacts and research gaps49
Real-world analysis of primary central nervous system diffuse large B-cell lymphoma49
Beyond the blood-brain barrier: Intranasal vaccines in cancer immunotherapy48
Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies48
Total neoadjuvant treatment and organ preservation strategies in the management of localized rectal cancer: A narrative review and evidence-based algorithm48
The hidden hand of endoplasmic reticulum stress in anticancer drug resistance46
The role of cGAS-STING in remodeling the tumor immune microenvironment induced by radiotherapy44
From immunohistochemistry to machine learning-based patient stratification by tumour proliferation characteristics in head and neck cancer43
Advancing tumor vaccines: Overcoming TME challenges, delivery strategies, and biomaterial-based vaccine for enhanced immunotherapy42
Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study41
A non-invasive miRNA-based approach in early diagnosis and therapeutics of oral cancer41
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era40
The cytokines in tumor microenvironment: from cancer initiation-elongation-progression to metastatic outgrowth39
Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models39
Novel insight into the Warburg effect: Sweet temptation38
Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions38
Current status of locally advanced rectal cancer therapy and future prospects38
0.20489287376404